Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma
Manoela Tiago(Administração Regional de Saúde de Lisboa e Vale do Tejo), Andrew E. Aplin(Thomas Jefferson University)
Cited by 25
Related Papers
Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis
|Cancer Discovery|2019|482
Akt3-Mediated Resistance to Apoptosis in B-RAF–Targeted Melanoma Cells
|Cancer Research|2010|194
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
|Nature Communications|2022|98
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms
|Cancer Discovery|2018|77
BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma
|Cell Death and Differentiation|2012|69